Practical Patient Care’s Post

We're proud to announce that Professor Yehuda Ringel will be presenting Alviv Laser Solutions's latest pre-clinical and clinical results at the @FNM conference. 📢 ALVIV LS is 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗙𝗲𝗰𝗮𝗹 𝗜𝗻𝗰𝗼𝗻𝘁𝗶𝗻𝗲𝗻𝗰𝗲 (𝗙𝗜) treatment through our innovative 𝗹𝗮𝘀𝗲𝗿-𝗯𝗮𝘀𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝘆. Unlike traditional approaches that focus solely on managing symptoms, our solution directly addresses the underlying cause through a series of quick, painless treatments. ✅ We're excited to share that our 𝗙𝗶𝗿𝘀𝘁-𝗶𝗻-𝗛𝘂𝗺𝗮𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗶𝘀 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗻𝗴 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆, with promising safety and feasibility outcomes. This marks a significant milestone in our mission to transform FI treatment. #MedicalInnovation #ClinicalTrials #MedTech #Healthcare #FNM2024 #BioTechnology"

Surgical staples: Current state-of-the-art and future prospective https://lnkd.in/gd2U_89x Thus, in this literature review, we try to give a comprehensive glimpse of the development and current state-of-the-art surgical staples in consideration with research from a commercial point of view. On a special note, this review also describes a very brief outline of the regulatory aspects and some common internationally acceptable ‘de jure standards for the development of commercially viable surgical staples. #Heterogeneity #innovation #research

🌟 Embarking on a Healthcare Revolution: Bioelectronic Medicine! 🌟 Envision a future where ailments are treated with precision and without invasive procedures. Bioelectronic medicine paves the way, employing tiny devices to interface with the body's electrical pathways, offering tailored therapies and minimizing reliance on pharmaceuticals. Let's explore this groundbreaking approach together, as we redefine healthcare for generations to come! #BioelectronicMedicine #InnovativeHealthcare #FutureOfMedicine 🚀🩺

Introducing MediMax MG, a state-of-the-art device setting a new standard in cell suspension preparation from solid tissue. 🌟 ✔ Automated Precision: Designed for mechanical disaggregation of human tissues, ensuring safe and standardized tissue preparation. ✔ Consistency & Reliability: Eliminates operator variability, enhancing the predictability and success of regenerative therapies. ✔ Essential Innovation: A crucial component of our tissue processing lineup, crafted with a profound understanding of regenerative medicine’s evolving needs. #MediMaxMG #RegenerativeMedicine #HealthcareInnovation #medicine #Medigraft #tissueengineering #innovationinmedicine

Attention #Medtech professionals! Are you interested in hemocompatibility, medical devices, and extracorporeal systems? Then, this exclusive editorial article is for you! It features experts Dr. Andy Herbert, CTO and Co-founder, and Dr. Elizabeth Blackburn, Principal Scientist at Invizius. Providing in-depth insights into the significance of assessing complement activation in dialysis. Don't miss out on this opportunity to enrich your knowledge and contribute to advancing healthcare solutions. Discover how Invizius is assessing complement activation and tackling its challenges. Click the link to download your copy and join the conversation on the relevance of hemocompatibility in extracorporeal systems. https://hubs.ly/Q02vv8PD0 Complement assessment could make a difference! #Hemocompatibility #ExtracorporealSystems #MedicalDevices #Dialysis #HealthcareInnovation #Biocompatibility #SvarLifeScience #ExpertPartner #AnswersinLifeScience #MedTech

Introducing MediMax MG, a state-of-the-art device setting a new standard in cell suspension preparation from solid tissue. 🌟 ✔ Automated Precision: Designed for mechanical disaggregation of human tissues, ensuring safe and standardized tissue preparation. ✔ Consistency & Reliability: Eliminates operator variability, enhancing the predictability and success of regenerative therapies. ✔ Essential Innovation: A crucial component of our tissue processing lineup, crafted with a profound understanding of regenerative medicine’s evolving needs. #MediMaxMG #RegenerativeMedicine #HealthcareInnovation #medicine #Medigraft #tissueengineering #innovationinmedicine

597% revenue growth? Not bad, Alafair Biosciences, Inc. It's great to see our portfolio company jump to No. 828 on the Inc. Magazine 5000 list and No. 11 in Health Products. This rapid success is driven by their game-changing VersaWrap® Hydrogel Sheet—improving surgical outcomes for thousands of patients across the U.S. and continuing to revolutionize soft tissue protection. At ATP Fund, we believe in visionary science that tackles humanity’s grand challenges—and Alafair is showing how it’s done. Read more on PR Newswire ▻ https://lnkd.in/gJ8fVCnP John Joyoprayitno Amy Shepherd Kyle Cox #HealthcareTech #VC #HealthcareInnovation #ScienceForGood #Inc5000 #ATPFund

Last but not least in our Clinical Market Spotlight series are diagnostics and laboratory products! ➡️ Did you know? The invention of the microscope in 1590 revolutionized the field of medical diagnostics. ➡️ Examples of products in this space include contrast media syringes, diagnostics consumables, tubing sets and containers, and filtration and collection, some of which are shown below. Click below to learn more about Viant's diagnostics and laboratory capabilities and stay tuned for more from our Clinical Market Spotlight series! https://lnkd.in/eXmpYgJE #Viant #medicaldevice #medtech #healthcare #diagnostics #clinical

🌟 FDA Approves Humacyte’s Symvess: A Milestone in Regenerative Medicine! 🌟 A groundbreaking moment in healthcare innovation—Humacyte's lab-grown blood vessel, Symvess, has received FDA approval, reshaping the future of vascular treatments. 🔬 Why Symvess Matters: Designed for urgent revascularization in traumatic limb injuries, it offers a life-saving alternative when a patient’s veins cannot be used. Engineered in a bioreactor and stripped of cellular components, it minimizes immune rejection while seamlessly integrating with the body. 💡 Clinical Impact: In trials, 67% of patients maintained blood flow without additional interventions within 30 days, showcasing its effectiveness. Provides a biodegradable, acellular solution, addressing the limitations of synthetic plastic-based vessels. 🚀 Transforming Healthcare: The approval of Symvess marks a significant step forward in regenerative medicine, opening new possibilities for lab-grown tissues and organs to address critical medical challenges. This innovation has the potential to transform how we approach complex vascular injuries and improve patient outcomes worldwide. #RegenerativeMedicine #FDAApproval #HealthcareInnovation #Humacyte #Symvess Link to the article in Endpoints News is : https://lnkd.in/g5E2cYwt

Revive™ is here to set a new standard in regenerative medicine by streamlining the isolation of therapeutic cells from adipose tissue. Our automated, centrifuge-free system tackles the usual challenges of adipose tissue processing, eliminating complexity, minimizing training, and reducing risks of clogging and contamination. Key Features: 1. Automated and Attractive: Enjoy fully automated operation post-setup with a visually appealing design suitable for clinical settings. 2. Time and Cost Efficient: Complete cell isolation in under 90 minutes, allowing your team to focus on other critical tasks. 3. Versatile Applications: Ideal for both treatment and ATMP production, providing a potent mix of mesenchymal stromal cells, regulatory T cells, endothelial progenitors, and pericytes. Revive™ is not just functionally innovative but also user-friendly, offering "plug and play" simplicity that drastically reduces operational complexity and training requirements. #ReviveRegeneration #RegenerativeMedicine #CellTherapy #BiotechInnovation #AutomatedIsolation #ClinicalExcellence #StemCells #AdiposeTissueProcessing